Beth Israel and Lahey merged into Massachusetts' No. 2 system — price-capped for 7 years

Beth Israel Deaconess Medical Center and Lahey Health had tried to merge multiple times before finally agreeing a deal in summer 2018. The combination would create Massachusetts' second-largest health system behind Partners HealthCare, and the state's Health Policy Commission warned it would likely raise prices, leaving BILH's market share nearly equal to Partners' with significantly enhanced bargaining leverage over commercial payers.

In November 2018 the Massachusetts attorney general approved the merger through a settlement with binding conditions: for seven years the combined system cannot raise prices beyond the state's healthcare cost growth benchmark, then set at 3.1%; it must participate in the state's Medicaid program indefinitely; it must increase access to mental health and substance use disorder treatment; and it must funnel significant investment into safety-net hospitals and programs.

The Federal Trade Commission, citing the settlement as one reason, declined to challenge the deal despite calling it 'not an easy decision'. The merger was expected to close in the first quarter of 2019, with Beth Israel Deaconess CEO Kevin Tabb serving as CEO of the combined Beth Israel Lahey Health.

Massachusetts' second-largest health system, share nearing Partners' — bought with a 7-year price cap at the state's 3.1% benchmark and indefinite Medicaid participation.

A template for merging in concentrated markets: conditions accepted up front instead of litigated.

The price cap is tied to a public benchmark (3.1%), making the remedy measurable year by year.

The FTC declined to block a deal state analysts said would likely raise prices — the settlement carried the day.

Health mergers can clear antitrust review without divestitures: Beth Israel Lahey bought approval by pre-committing to capped prices, Medicaid access and safety-net spending for years.

Approval ended intense scrutiny of the merger. The material records closing as expected in the first quarter of 2019, with Tabb set to lead the combined system.